EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 86 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,617,305 | -4.1% | 1,829,450 | +4.4% | 0.00% | – |
| Q2 2023 | $15,248,247 | +240.5% | 1,752,672 | +15.1% | 0.00% | – |
| Q1 2023 | $4,477,823 | -23.8% | 1,523,069 | -9.3% | 0.00% | – |
| Q4 2022 | $5,874,622 | -55.0% | 1,678,463 | +1.7% | 0.00% | – |
| Q3 2022 | $13,060,000 | +5.8% | 1,651,029 | +5.2% | 0.00% | – |
| Q2 2022 | $12,347,000 | -33.4% | 1,568,762 | +2.8% | 0.00% | – |
| Q1 2022 | $18,543,000 | +5.2% | 1,526,153 | +5.9% | 0.00% | – |
| Q4 2021 | $17,633,000 | +42.1% | 1,440,631 | +21.0% | 0.00% | – |
| Q3 2021 | $12,407,000 | +22.2% | 1,190,633 | +5.4% | 0.00% | – |
| Q2 2021 | $10,156,000 | +44056.5% | 1,129,744 | +48849.0% | 0.00% | – |
| Q1 2021 | $23,000 | -96.5% | 2,308 | -97.7% | 0.00% | – |
| Q4 2020 | $662,000 | – | 100,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,190,921 | $50,920,000 | 12.31% |
| ACUTA CAPITAL PARTNERS, LLC | 307,944 | $3,742,000 | 1.75% |
| Samsara BioCapital, LLC | 480,000 | $5,832,000 | 1.47% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,909,407 | $35,349,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,666 | $2,256,000 | 0.93% |
| Altium Capital Management LP | 224,541 | $2,728,000 | 0.91% |
| RA Capital Management | 3,370,506 | $40,952,000 | 0.89% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 276,591 | $3,361,000 | 0.42% |
| MYDA Advisors LLC | 55,000 | $668,000 | 0.26% |
| Atom Investors LP | 40,855 | $496,000 | 0.23% |